ARCHIVE

• Blood Glucose Control Improved by Ultra-fast Acting Insulin: Lilly Symposium
  August 6, 2001

• Nippon Kayaku to Place Top Priority on R&D
  August 6, 2001

• Large Studies Required to Verify Inhibition of Cardiovascular Events: Sankyo Seminar
  August 6, 2001

• Shimadzu: HPLC Autosampler SIL-HT
  July 30, 2001

• Asahi Glass Ties Up with DMS Biologics to Contract to Manufacture Biotechnology Drugs
  July 30, 2001

• Industry FTC to Prohibit Free Loan of Medical Devices
  July 30, 2001

• Tanabe Licenses Bepotastine to Senju as Eye Drop
  July 30, 2001

• Differences in Prices of Catheters in Japan, Abroad Highlighted: JSIC Meeting
  July 30, 2001

• Makers Accelerating Business Restructuring
  July 30, 2001

• WORLD NEWS IN BRIEF
  July 30, 2001

• Drug Dispensing Cost Outstrips Dental Care Cost
  July 30, 2001

• JST Select 10 Research Themes to Support in FY2001
  July 30, 2001

• 5 Products Including NovoRapid, Isuhuman, Flutide Recommended for Approval
  July 30, 2001

• Glivec Highly Effective against CML: Novartis Seminar
  July 30, 2001

• Stomach Cancer to Be Approved as New Indication for Taxol
  July 30, 2001

• Risperdal Effective for Positive Symptoms of Schizophrenia: Dr Grogg of Janssen
  July 30, 2001

• World Anti-cancer Market to Expand to \3 Trillion in 2005: Consultant
  July 30, 2001

• Int'l Study on Rofecoxib in OA Patients Begins: Banyu, Merck
  July 30, 2001

• Kyowa Hakko Enters PI in Europe for Anti-asthma KW-4490
  July 30, 2001

• Only 5% of Migraine Sufferers Seek Professional Help: GSK Seminar
  July 30, 2001

ページ

• « 先頭
• ‹ Prev
• …
• 739
• 740
• 741
• 742
• 743
• 744
• 745
• 746
• 747
• …
• Next ›
• 最終 »